Nouscom is dedicated to developing next generation immunotherapies to beat cancer

Pic-5-3

Senior Management and Founders

  • Cortese

    Riccardo Cortese, PhD, MD

    Chairman of the Board, Chief Executive Officer and co-founder

    Riccardo founded the genetic vaccine company Okairos in 2007 and led the company through its successful acquisition by GSK in 2013.

    Read more
  • Alfredo

    Alfredo Nicosia, PhD

    Chief Executive Officer Italy and co-founder

    Alfredo was a co-founder of Okairos and served as the company’s Chief Scientific Officer.

    Read more
  • Scarselli

    Elisa Scarselli, MD

    Chief Scientific Officer and co-founder

    Elisa became part of the Okairos team in 2010 and served as the company’s Clinical Director.

    Read more
  • Colloca

    Stefano Colloca, MD

    Chief Technical Officer and co-founder

    Stefano was a co-founder of Okairos and served as the company’s Senior Director for Vector Development.

    Read more
  • Folgori

    Antonella Folgori, PhD

    Head of Immunology and co-founder

    Antonella was a co-founder of Okairos and served as the company’s Director of Immunology.

    Read more
  • Traboni

    Cinzia Traboni, PhD

    Senior Director of Regulatory Affairs and co-founder

    Cinzia was part of the Okairos team from 2007 onward, heading the Regulatory Affairs function.

    Read more
  • udier

    Marina Udier, PhD

    Chief Operating Officer

    Marina was an Operating Principal with Versant Ventures where she collaborated with multiple new and existing portfolio companies.

    Read more

Board of Directors

  • Prieels

    Jean Paul Prieels, PhD

    Member

    He is a Director of Vaximm and on the independent Advisory Board of Curevac.

    Read more
  • Rothe

    Dr. Joachim (JR) Rothe, PhD

    Member

    He is currently Managing Partner and Co-Owner of LSP.

    Read more
  • Magni

    Guido Magni, MD

    Member

    He is a Partner with Versant Ventures and serves on the Board of Biotie and AM Pharma.

    Read more
  • Gromo

    Gianni Gromo, MD

    Observer

    Gianni is a Partner with Versant Ventures and serves on the Board of Novira Therapeutics and Piqur.

    Read more

Key Advisors

  • Campadelli

    Prof. Gabriella Campadelli

    Advisor and co-founder

    She has pioneered the field of retargeting/detargeting the tropism of HSV to cancer specific receptors.

    Read more
  • Brichard

    Vincent Brichard

    He is an independent board member of Etherna and is part of the Scientific Advisory Board of Imcyse.

    Read more
  • Shiver

    John Shiver, PhD

    He is Sr. Vice President, Research and Development with Sanofi Pasteur since 2013.

    Read more